The European Medicines Verification Organisation (EMVO) is dedicated to securing the legal supply chain from falsified medicines for patient safety in Europe. Founded in 2016 and headquartered in Belgium, EMVO is pivotal in advancing the formation of the European Medicines Verification System (EMVS) in alignment with the EU’s Falsified Medicines Directive (FMD) and the Delegated Regulation (DR). This system aims to ensure the implementation of a functioning, secure, interoperable, and cost-effective solution across Europe, effectively combating the infiltration of falsified medicines in the supply chain. EMVO has been established as a joint initiative of EU stakeholders, representing manufacturers (Medicines for Europe, EFPIA, Affordable Medicines Europe), wholesalers (GIRP), and community pharmacists (PGEU). With patient health and safety being a top priority for the pharmaceutical industry, the creation of EMVO signifies the need for a comprehensive strategy at the European level. You can follow EMVO on Twitter: @emvo_official and visit their website: www.emvo-medicines.eu.
There is no investment information
No recent news or press coverage available for EMVO | European Medicines Verification Organisation.